$GILD Lots of big boys are still not fully convinced. Again, $GILD needs 3 things to gain their confidence. 1) clear cut study result which shows Remdesivir is effective * 2) FDA approval 3) profitable price setting * The recent study from New England Journal of Medicine (NEJM) almost met requirement * 1). NEJM stated that โ€œ Remdesivir MAY have clinical benefit in patients with severe Covid-19. โ€œ I am cautiously optimistic about this stock now. GILD may further decline slightly near future, but a big โšก๏ธ๐Ÿ’ฅโšก๏ธ๐Ÿ’ฅ๐Ÿš€ is expected within 7-14 days. This is my prediction. nejm.org/action/cookieAbsent
  • 8